Clinical Trial Update: A Study of Safety and Immunogenicity of a Malaria Vaccine Candidate [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating safety and immunogenicity of a malaria vaccine candidate has completed. The sponsor reported completion of a Phase 1 trial assessing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• Malaria vaccine candidate (name not disclosed)

Snippet

Sponsor: Shanghai Wanxing Bio-Pharmaceutical Co. Ltd. | Conditions: Prophylaxis Against Plasmodium Falciparum Malaria | Phase 1 | Status: COMPLETED